Revenue
2019
2020
2021
2022
2023
2024
2025
P3 Health Partners Inc. (PIII)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2019
2020
2021
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.50B | $1.27B | $1.05B | $578.6M | $491.1M | $145.5M |
| Operating expenses | $1.73B | $1.82B | $1.43B | $2.61B | $707.7M | $519.7M | $185.0M |
| Operating income | −$270.3M | −$320.7M | −$167.9M | −$1.56B | −$129.1M | −$28.6M | −$39.5M |
| EBITDAderived | −$186.1M | −$234.6M | −$81.3M | −$1.47B | −$127.5M | −$27.8M | −$39.1M |
| Net income | −$147.9M | −$135.8M | −$57.8M | −$270.1M | −$146.4M | −$31.4M | −$42.0M |
| Basic EPSper diluted share | -$45.26 | -$46.78 | -$0.61 | -$6.50 | — | — | — |
| Diluted EPSper diluted share | -$45.26 | -$54.06 | -$0.63 | -$6.50 | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 4, 2025Form 4 | Chicago Pacific Founders UGP III, LLC +1TenPercentOwner | BuyWarrants to Purchase Class A Common Stock · derivative · indirect | 1.43M | $0.00 | $0.00 | 1.43M |
| Dec 12, 2024Form 4 | Chicago Pacific Founders UGP III, LLC +1TenPercentOwner | BuyWarrant to Purchase Class A Common Stock · derivative · indirect | 71.41M | $0.00 | $0.00 | 71.41M |
| Sep 13, 2024Form 4 | CPF III-A PT SPV, LLC +3TenPercentOwner | BuyClass A Common Stock · indirect | 80.0K | $0.50 | $40.0K | 77.19M |
| Sep 12, 2024Form 4 | CPF III-A PT SPV, LLC +3TenPercentOwner | BuyClass A Common Stock · indirect | 80.0K | $0.52 | $41.6K | 77.11M |
| Sep 11, 2024Form 4 | Chicago Pacific Founders GP III, L.P. +3TenPercentOwner | BuyClass A Common Stock · indirect | 80.0K | $0.56 | $44.8K | 77.03M |